Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease. Levels of a key protein — called TLR2 — in tumors was found to predict a patient’s survival after being diagnosed with lung cancer, a study shows. A drug compound that activates TLR2 was tested in mice and was found to reduce tumor growth in the early stages of the disease.
Brabus Launches ‘Deep Blue’ G-Wagon, Speedboat & Luxury Watch Line
Brabus is unifying its collaborations with Mercedes-AMG, Finland’s Axopar Boats, and Panerai luxury watches under one Deep Blue collection.Being that Brabus is...
